Skills this job asks for
ComplianceLeadershipProduct managementTranslationRisk management
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Glaxosmithkline LLC paid sponsored hires in similar roles4 certified filings for “Associate Director – Genomic Technologies” (Molecular and Cellular Biologists) in PA: $134k–$138k, median $136k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles
- 4 certified filings for “Associate Director – Genomic Technologies” (Molecular and Cellular Biologists) in PA: $134k–$138k, median $136k. Most were filed at wage level IV (50%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Business Introduction
GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems.
Our diverse portfolio consists of vaccines, specialty medicines, and general medicines.
Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges.
Position Summary
The Senior Director, Risk Automation & Intelligence leads the strategy and execution of the data, analytics and automation capabilities that the rest of the Technology Risk and Compliance function relies on to manage risk and demonstrate compliance effectively and efficiently. This is a senior leadership role accountable for the capability across GSK, spanning policy, process, automation and tooling, training and end-user experience for Technology Risk and Compliance capabilities and services.
About the team. Risk Automation and Intelligence is the engine room of the Risk and Compliance function's data and automation, operating as GSK's Risk Operations Centre. The team builds future-ready analytics, automation and intelligence that enable GSK to manage technology risk and compliance proactively and at scale.
Key responsibilities:
This role will provide you the opportunity to lead key activities to progress your career. These responsibilities include some of the following:
• Set the enterprise vision and multi-year strategy for the data, analytics and automation capabilities that underpin Technology Risk and Compliance at GSK, and secure the investment to deliver it.
• Lead the Risk Automation & Intelligence organisation, including leaders of teams, and own its capability plan.
• Own the budget, vendor portfolio and headcount plan for the capability.
• Represent the capability to the CISO, GSK Tech leadership, auditors and regulators.
• Own GSK's Cyber Security Policies, ensuring they remain current, practical and aligned with the evolving threat, technology and regulatory landscape.
• Own the Technology Risk and Compliance processes used across GSK, ensuring they are well-designed, consistently applied and continuously improved.
• Own the integration between Technology Risk and Compliance and GSK's Enterprise Risk Programme, ensuring technology risk is represented accurately and consistently in enterprise risk reporting and governance.
• Operate and evolve GSK's Risk Operations Centre model, bringing modern Risk Operations Centre concepts, continuous controls monitoring and quantitative risk analysis into how GSK manages technology risk and compliance.
• Bring product management rigour to the roadmap for risk and compliance tooling, translating the needs of stakeholders at Director, VP and SVP level into prioritised features and releases.
• Build and lead the capability that automates risk, control and compliance processes, including AI and intelligent automation, to replace manual effort with proactive, at-scale risk management.
• Develop risk analytics, models and quantitative risk methods that help the business identify, evaluate and treat cyber risk, and that support prioritisation and inform resource and investment decisions for leadership, ExCom and the Board.
• Develop performance analytics that measure the effectiveness and operational efficiency of the Technology Risk and Compliance programme itself, driving continuous improvement.
• Own the data
Apply on employer site ↗